The gastric cancer diagnostic procedure market is expected to grow from US$ 1307.96 million in 2022 to US$ 1912.03 million by 2028; it is estimated to register a CAGR of 6.5% from 2022 to 2028.
The gastric cancer diagnostic procedure market is segmented on the basis of healthcare provider, symptom type, body fluid, procedure, offering, disease indication, and geography. The report offers insights and in-depth analysis of the market, emphasizing parameters such as dynamics, trends, and opportunities in the gastric cancer diagnostic procedure market and competitive landscape analysis of leading market players across various regions. It also includes the impact analysis of COVID–19 pandemic on the market across these regions.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Gastric Cancer Diagnostic Procedure Market: Strategic Insights
Market Size Value in US$ 1307.96 million in 2022 Market Size Value by US$ 1912.03 million by 2028 Growth rate CAGR of 6.5% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Gastric Cancer Diagnostic Procedure Market: Strategic Insights
Market Size Value in | US$ 1307.96 million in 2022 |
Market Size Value by | US$ 1912.03 million by 2028 |
Growth rate | CAGR of 6.5% from 2022 to 2028 |
Forecast Period | 2022-2028 |
Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystMarket Insights
Rise in Prevalence of Gastrointestinal Diseases
Despite declining incidence and mortality during the last decades, stomach cancer is perceived as one of the main health challenges worldwide. According to the GLOBOCAN, stomach cancer caused ~800,000 deaths (accounting for 7.7% of all cancer-related deaths) in 2020. The disease ranks as the fourth leading cause of cancer deaths in both genders combined. ~1.1 million new cases of stomach cancer were diagnosed in 2020, accounting for 5.6% of all cancer cases. Asia accounts for ~75% of the new stomach cancer cases and deaths reported globally. Western countries, such as the US and Canada, report high GI disease incidence rates, which can be attributed to increasing obesity in the adult population and less consumption of dietary fibers. According to data released by the Centers for Disease Control and Prevention in December 2022, physicians’ offices in the US record ~37.2 million cases of digestive system diseases.
The prevalence of irritable bowel syndrome (IBS) has increased across the world in the last few decades. According to the International Foundation for Gastrointestinal Disorders, Inc., IBS is the most common functional GI disorder, with a global prevalence rate of 10–15%. Also, physicians in the US record ~2.4–3.5 million visits of IBS patients annually. Although the overall incidence rate of gastric cancer has been declining over the years, it has surged among young adults during the past several decades. Thus, the increasing prevalence of gastrointestinal (GI) disease results in a high risk of developing gastric cancer, which drives the growth of the gastric cancer diagnostic procedure market.
Healthcare Provider-Based Insights
The global gastric cancer diagnostic procedure market, based on healthcare provider, is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, and others. In 2022, the hospitals segment held the largest share of the market. The market for the cancer research institutes segment is expected to grow at the highest CAGR during the forecast period.
Symptom Type-Based Insights
The gastric cancer diagnostic procedure market, by symptom type, is bifurcated into symptomatic and asymptomatic. In 2022, the asymptomatic segment held a larger market share. However, the symptomatic segment is estimated to register a higher CAGR during the forecast period.
Body Fluid-Based Insights
Based on body fluid, the gastric cancer diagnostic procedure market is segmented into blood, urine, saliva, stomach wash/gastric juice, tissue, and others. In 2022, the blood segment held the largest market share. However, the market for the tissue segment is expected to grow at the fastest CAGR during the forecast period.
Procedure-Based Insights
Based on procedure, the gastric cancer diagnostic procedure market is segmented into endoscopic procedures, biopsy and tissue tests, lab tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics and immunoassays, and others. In 2022, the imaging tests segment held the largest market share. The market for the biopsy and tissue tests segment is estimated to register a higher CAGR during the forecast period.
Offering-Based Insights
The gastric cancer diagnostic procedure market, based on offerings, is segmented into instruments, reagents and consumables, and services. In 2022, the reagents and consumables segment held the largest share of the market. The market for the services segment is estimated to register a higher CAGR during the forecast period.
Disease Indication-Based Insights
Based on disease indication, the gastric cancer diagnostic procedure market is segmented into early gastric cancer and advanced gastric cancer. In 2022, the advanced gastric cancer segment held a larger share of the market. The market for the same segment is expected to grow at a higher CAGR during the forecast period.
COVID-19 Insights
Preventive measures such as deliberately expanding the physical space to avoid close contacts and spread of illness, and mandating the use of masks in workplaces were implemented in several countries for reducing the spread of SARS-CoV-2. However, various restrictions resulted in the cancellation or rescheduling of appointments for gastric cancer diagnosis and treatments. According to a study published in 2021 in PubMed, significantly fewer patients were diagnosed with stage-I gastric and colorectal cancers during the COVID-19 phase. After the first quarter of 2020, the demand for gastric cancer diagnostics increased in the government and private institutions for testing COVID-19 patients for H. pylori infection. Furthermore, patients with advanced stages of gastric cancer were prioritized for diagnosis and treatment, which led to the gastric cancer diagnostic procedure market growth amid the COVID-19 crisis.
Gastric Cancer Diagnostic Procedure Market Report Scope
The gastric cancer diagnostic procedure market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide and meet the growing demand. Partnerships and collaborations are among the inorganic growth strategies witnessed in the market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence. Additionally, acquisitions, partnerships, and other growth strategies help companies to strengthen customer base and increase their product portfolios.
- In February 2023, CARsgen Therapeutics announced a collaboration agreement with F. Hoffmann-La Roche (Roche) to assess AB011 and atezolizumab to treat gastric cancer. The collaboration will evaluate CARsgen’s investigational drug AB011, Roche’s PD-L1 checkpoint inhibitor atezolizumab, and the standard-of-care chemotherapy combination in gastric or gastroesophageal junction carcinoma patients.
- In January 2023, Agilent Technologies announced a partnership with Akoya Biosciences to develop chromogenic and immunofluorescent multiplex assays that include spatial analysis for biopharma companies engaged in developing precision cancer therapeutics. This partnership enables an ecosystem that assists the development of novel precision cancer therapeutics and offers a streamlined workflow to the customers of both these companies in the clinical research market.
- In August 2022, MiRXES launched a series of new capabilities—including an Industry 4.0 manufacturing facility, two new laboratories, and a collaborative multi-cancer screening research project. The new developments are aligned with MiRXES’ goal of advancing its research and production capabilities to develop miRNA-based disease detection tests.
- In July 2022, MiRXES Pte Ltd launched the world’s first large-scale clinical research project—CADENCE (CAncer Detected Early caN be CurEd). The Project CADENCE aims to develop a multi-cancer early detection test for up to nine high-incidence and high-mortality cancers: lung, breast, colorectal, liver, stomach (gastric), esophageal, ovarian, pancreatic, and prostate cancers.
Gastric Cancer Diagnostic Procedure Market - Company Profiles
- Atlas-Link Biotech Co Ltd
- Bio-Rad Laboratories Inc
- MiRXES Pte Ltd
- Agilent Technologies Inc
- F. Hoffmann-La Roche Ltd
- bioMerieux SA
- Thermo Fisher Scientific Inc
- Illumina Inc
- Vela Diagnostics Holding Pte Ltd
- Myraid Genetics Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Healthcare Provider, Symptom Type, Body Fluid, Procedure, Offering, and Disease Indication
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors that are driving the growth of the gastric cancer diagnostic procedure market are the rise in alcohol consumption, smoking, surging cases of Helicobacter pylori infection, and the rise in the prevalence of gastrointestinal diseases. These are some of the major factors contributing to the growth of the gastric cancer diagnostic procedure industry.
Gastric cancer is a type of malignant cancer that forms the stomach's inner lining. Risk factors such as age, diet, and stomach diseases can lead to the development of gastric cancer. Symptoms of gastric cancer include indigestion, heartburn, bloating, and stomach discomfort or pain.
The gastric cancer diagnostic procedure market majorly consists of the players, such as Atlas-Link Biotech Co Ltd, Bio-Rad Laboratories Inc, MiRXES Pte Ltd, Agilent Technologies Inc, F. Hoffmann-La Roche Ltd, bioMerieux SA, Thermo Fisher Scientific Inc, Illumina Inc, Vela Diagnostics Holding Pte Ltd, and Myraid Genetics Inc.
The gastric cancer diagnostic procedure market is estimated to be valued at US$ 1307.96 million in 2022.
The CAGR value of the gastric cancer diagnostic procedure market during the forecasted period is 6.5%%.
The Asia Pacific is expected to be the fastest-growing region in the gastric cancer diagnostic procedure market over the forecast period due to the increasing surging cases of helicobacter pylori infection and the rise in the prevalence of gastrointestinal diseases.
The gastric cancer diagnostic procedure market is expected to be valued at US$ 1912.03 million by 2028.
The hospitals segment held the largest share of the market in 2022. Also, the cancer research institutes segment is estimated to register the highest CAGR in the market during the forecast period.
1. Introduction 66
1.1 Scope of the Study. 66
1.2 The Insight Partners Research Report Guidance. 66
1.3 Market Segmentation. 67
1.3.1 Global Gastric cancer diagnostic procedure Market – by Healthcare Providers. 68
1.3.2 Global Gastric Cancer Diagnostic Procedure Market – By Symptom Types. 69
1.3.3 Global Gastric Cancer Diagnostic Procedure Market – By Body Fluid. 69
1.3.4 Global Gastric Cancer Diagnostic Procedure Market – By Procedures. 69
1.3.5 Global Gastric Cancer Diagnostic Procedure Market – By Offerings. 70
1.3.6 Global Gastric Cancer Diagnostic Procedure Market – By Disease Indication. 70
1.3.7 Global Gastric cancer diagnostic procedure Market – by Geography. 70
2. Gastric Cancer Diagnostic Procedure Market – Key Takeaways 72
3. Research Methodology 78
3.1 Coverage. 79
3.2 Secondary Research. 79
3.3 Primary Research. 80
4. Gastric cancer diagnostic procedure Market – Market Landscape 81
4.1 Overview.. 81
4.2 PEST Analysis. 81
4.2.1 North America PEST Analysis. 81
4.2.2 Europe PEST Analysis. 82
4.2.3 Asia Pacific PEST Analysis. 82
4.2.4 South & Central America PEST Analysis. 83
4.2.5 Middle East & Africa PEST Analysis. 83
4.3 Expert’s Opinion. 84
5. Gastric Cancer Diagnostic Procedure Market – Key Market Dynamics 85
5.1 Market Drivers. 85
5.1.1 Rise in Prevalence of Gastrointestinal Diseases. 85
5.1.2 Surging Cases of Helicobacter Pylori Infection. 85
5.2 Market Restraints. 86
5.2.1 Shortage of Medical Laboratory Professionals. 86
5.3 Market Opportunities. 86
5.3.1 Rising Awareness of Gastric Cancer 86
5.4 Future Trends. 87
5.4.1 Development of AI-Based Gastric Cancer Diagnostic Platform... 87
5.5 Impact Analysis. 88
6. Gastric Cancer Diagnostic Procedure Market – Global Analysis 89
6.1 Global Gastric Cancer Diagnostic Procedure Market Revenue Forecast and Analysis. 89
6.2 Global Gastric Cancer Diagnostic Procedure Market, by Geography – Forecast and Analysis. 90
6.3 Market Positioning of Key Players. 91
6.4 Global Gastric Cancer Diagnostic Procedure Market – Market Potential Analysis, by Region. 91
6.5 Comparative Company Analysis. 92
6.6 Growth Strategy Analysis. 93
6.7 Performance of Key Players. 94
6.7.1 F. Hoffmann-La Roche Ltd. 94
6.7.2 Thermo Fisher Scientific Inc. 95
7. Global Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 – by Healthcare Providers 96
7.1 Overview.. 96
7.2 Diagnostic Laboratories. 97
7.2.1 Overview.. 97
7.2.2 Diagnostic Laboratories: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 97
7.3 Hospitals. 98
7.3.1 Overview.. 98
7.3.2 Hospitals: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 98
7.4 Cancer Research Institutes. 99
7.4.1 Overview.. 99
7.4.2 Cancer Research Institutes: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 99
7.5 Oncology Specialty Clinics. 100
7.5.1 Overview.. 100
7.5.2 Oncology Specialty Clinics: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 100
7.6 Others. 101
7.6.1 Overview.. 101
7.6.2 Others: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 101
8. Global Gastric Cancer Diagnostic Procedure Market Analysis and Forecasts to 2028 – by Symptom Types 102
8.1 Overview.. 102
8.2 Symptomatic. 103
8.2.1 Overview.. 103
8.2.2 Symptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 103
8.3 Asymptomatic. 104
8.3.1 Overview.. 104
8.3.2 Asymptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 104
9. Global Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 – by Body Fluid 105
9.1 Overview.. 105
9.2 Blood. 106
9.2.1 Overview.. 106
9.2.2 Blood: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 106
9.3 Urine. 107
9.3.1 Overview.. 107
9.3.2 Urine: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 107
9.4 Saliva. 108
9.4.1 Overview.. 108
9.4.2 Saliva: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 108
9.5 Stomach Wash/Gastric Juice. 109
9.5.1 Overview.. 109
9.5.2 Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 109
9.6 Tissue. 110
9.6.1 Overview.. 110
9.6.2 Tissue: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 110
9.7 Others. 111
9.7.1 Overview.. 111
9.7.2 Other: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 111
10. Global Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 – by Procedure 112
10.1 Overview.. 112
10.2 Endoscopic Procedure. 113
10.2.1 Overview.. 113
10.2.2 Endoscopic Procedure: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 113
10.3 Biopsy and Tissue Tests. 114
10.3.1 Overview.. 114
10.3.2 Biopsy and Tissue Tests: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 114
10.4 Lab Tests. 115
10.4.1 Overview.. 115
10.4.2 Lab Tests: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 115
10.5 In-Vitro Diagnostic Tests. 116
10.5.1 Overview.. 116
10.5.2 In-Vitro Diagnostic Tests: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 116
10.6 Imaging Tests. 117
10.6.1 Overview.. 117
10.6.2 Imaging Tests: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 117
10.7 Molecular Diagnostics. 118
10.7.1 Overview.. 118
10.7.2 Molecular Diagnostics: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 118
10.8 Multiplexing Molecular Diagnostics and Immunoassay. 119
10.8.1 Overview.. 119
10.8.2 Multiplexing Molecular Diagnostics and Immunoassay: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 119
10.9 Others. 121
10.9.1 Overview.. 121
10.9.2 Others: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 121
11. Global Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 – by Offerings 122
11.1 Overview.. 122
11.2 Instruments. 123
11.2.1 Overview.. 123
11.2.2 Instruments: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 123
11.3 Reagents and Consumables. 124
11.3.1 Overview.. 124
11.3.2 Reagents and Consumables: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 124
11.4 Services. 125
11.4.1 Overview.. 125
11.4.2 Services: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 125
12. Global Gastric Cancer Diagnostic Procedure Analysis – by Disease Indication 126
12.1 Overview.. 126
12.2 Early Gastric Cancer 127
12.2.1 Overview.. 127
12.2.2 Early Gastric Cancer: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 127
12.3 Gastric Cancer Advanced Types. 128
12.3.1 Overview.. 128
12.3.2 Gastric Cancer Advanced Types: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 128
13. Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 – Geographic Analysis 129
13.1 North America: Gastric Cancer Diagnostic Procedure Market 129
13.1.1 Overview.. 129
13.1.2 North America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 130
13.1.3 North America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 130
13.1.3.1 North America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 131
13.1.3.2 North America: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 131
13.1.3.3 North America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 131
13.1.3.4 North America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 132
13.1.4 North America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 132
13.1.5 North America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 133
13.1.6 North America: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 133
13.1.6.1 North America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 134
13.1.6.2 North America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 134
13.1.6.3 North America: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 134
13.1.6.4 North America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 135
13.1.6.5 North America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 135
13.1.7 North America: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 136
13.1.8 North America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 136
13.1.9 North America: Gastric Cancer Diagnostic Procedure Market, by Country. 137
13.1.9.1 US: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 137
13.1.9.1.1 Overview.. 137
13.1.9.1.2 United States: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 138
13.1.9.1.3 United States: Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 138
13.1.9.1.3.1 United States: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 139
13.1.9.1.3.2 United States: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 139
13.1.9.1.3.3 United States: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 140
13.1.9.1.3.4 United States: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 140
13.1.9.1.4 United States: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 140
13.1.9.1.5 United States: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 141
13.1.9.1.6 United States: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 141
13.1.9.1.6.1 United States: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 142
13.1.9.1.6.2 United States: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 142
13.1.9.1.6.3 United States: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 143
13.1.9.1.6.4 United States: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 143
13.1.9.1.6.5 United States: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 144
13.1.9.1.7 United States: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 144
13.1.9.1.8 United States: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 145
13.1.9.2 Canada: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 146
13.1.9.2.1 Overview.. 146
13.1.9.2.2 Canada: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 146
13.1.9.2.3 Canada: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 147
13.1.9.2.3.1 Canada: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 148
13.1.9.2.3.2 Canada: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 148
13.1.9.2.3.3 Canada: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 148
13.1.9.2.3.4 Canada: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 149
13.1.9.2.4 Canada: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 149
13.1.9.2.5 Canada: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 150
13.1.9.2.6 Canada: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 150
13.1.9.2.6.1 Canada: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 151
13.1.9.2.6.2 Canada: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 151
13.1.9.2.6.3 Canada: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 152
13.1.9.2.6.4 Canada Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 152
13.1.9.2.6.5 Canada Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 153
13.1.9.2.7 Canada Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 153
13.1.9.2.8 Canada Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 154
13.1.9.3 Mexico: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 155
13.1.9.3.1 Overview.. 155
13.1.9.3.2 Mexico: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 155
13.1.9.3.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 156
13.1.9.3.3.1 Mexico: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 156
13.1.9.3.3.2 Mexico: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 157
13.1.9.3.3.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 157
13.1.9.3.3.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 157
13.1.9.3.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 158
13.1.9.3.5 Mexico: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 158
13.1.9.3.6 Mexico: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 159
13.1.9.3.6.1 Mexico: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 159
13.1.9.3.6.2 Mexico: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 160
13.1.9.3.6.3 Mexico: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 160
13.1.9.3.6.4 Mexico: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 161
13.1.9.3.6.5 Mexico: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 161
13.1.9.3.7 Mexico: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 162
13.1.9.3.8 Mexico: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 162
13.2 Europe: Gastric Cancer Diagnostic Procedure Market 163
13.2.1 Overview.. 163
13.2.2 Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 164
13.2.3 Europe: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 164
13.2.3.1 Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 165
13.2.3.2 Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 165
13.2.3.3 Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 165
13.2.3.4 Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 166
13.2.4 Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 166
13.2.5 Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 166
13.2.6 Europe Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 167
13.2.6.1 Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 167
13.2.6.2 Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 168
13.2.6.3 Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 168
13.2.6.4 Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 169
13.2.6.5 Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 169
13.2.7 Europe Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 170
13.2.8 Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 170
13.2.9 Europe: Gastric Cancer Diagnostic Procedure Market, by Country. 171
13.2.9.1 Germany: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 171
13.2.9.1.1 Overview.. 171
13.2.9.1.2 Germany Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 172
13.2.9.1.3 Germany Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 172
13.2.9.1.3.1 Germany Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 173
13.2.9.1.3.2 Germany Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 173
13.2.9.1.3.3 Germany Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 173
13.2.9.1.3.4 Germany Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 174
13.2.9.1.4 Germany Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 174
13.2.9.1.5 Germany Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 175
13.2.9.1.6 Germany Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 175
13.2.9.1.6.1 Germany Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 176
13.2.9.1.6.2 Germany Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 176
13.2.9.1.6.3 Germany Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 177
13.2.9.1.6.4 Germany Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 177
13.2.9.1.6.5 Germany Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 178
13.2.9.1.7 Germany Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 178
13.2.9.1.8 Germany Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 179
13.2.9.2 France: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 180
13.2.9.2.1 Overview.. 180
13.2.9.2.2 France: Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million) 181
13.2.9.2.3 France: Gastric Cancer Diagnostic Procedure Market, by Healthcare providers, 2019–2028 (US$ Million) 181
13.2.9.2.3.1 France: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 182
13.2.9.2.3.2 France: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 182
13.2.9.2.3.3 France: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 182
13.2.9.2.3.4 France: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 183
13.2.9.2.4 France: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 183
13.2.9.2.5 France: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 184
13.2.9.2.6 France: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 184
13.2.9.2.6.1 France: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 185
13.2.9.2.6.2 France: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 185
13.2.9.2.6.3 France: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 186
13.2.9.2.6.4 France Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 186
13.2.9.2.6.5 France Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 187
13.2.9.2.7 France Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 187
13.2.9.2.8 France Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 188
13.2.9.3 UK: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 189
13.2.9.3.1 Overview.. 189
13.2.9.3.2 UK: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 189
13.2.9.3.3 UK: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 190
13.2.9.3.3.1 UK: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 191
13.2.9.3.3.2 UK: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 191
13.2.9.3.3.3 UK: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 191
13.2.9.3.3.4 UK: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 192
13.2.9.3.4 UK: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 192
13.2.9.3.5 UK: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 192
13.2.9.3.6 UK: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 193
13.2.9.3.6.1 UK: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 193
13.2.9.3.6.2 UK: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 194
13.2.9.3.6.3 UK: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 194
13.2.9.3.6.4 UK: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 195
13.2.9.3.6.5 UK: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 195
13.2.9.3.7 UK: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 196
13.2.9.3.8 UK: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 196
13.2.9.4 Italy: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 197
13.2.9.4.1 Overview.. 197
13.2.9.4.2 Italy: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 197
13.2.9.4.3 Italy: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 198
13.2.9.4.3.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 198
13.2.9.4.3.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 199
13.2.9.4.3.3 Italy: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 199
13.2.9.4.3.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 199
13.2.9.4.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 200
13.2.9.4.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 200
13.2.9.4.6 Italy: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 201
13.2.9.4.6.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 201
13.2.9.4.6.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 202
13.2.9.4.6.3 Italy: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 202
13.2.9.4.6.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 203
13.2.9.4.6.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 203
13.2.9.4.7 Italy: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 204
13.2.9.4.8 Italy: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 204
13.2.9.5 Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 205
13.2.9.5.1 Overview.. 205
13.2.9.5.2 Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 205
13.2.9.5.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 206
13.2.9.5.3.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 206
13.2.9.5.3.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 206
13.2.9.5.3.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 207
13.2.9.5.3.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 207
13.2.9.5.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 208
13.2.9.5.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 208
13.2.9.5.6 Spain: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 209
13.2.9.5.6.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 209
13.2.9.5.6.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 210
13.2.9.5.6.3 Spain: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 210
13.2.9.5.6.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 211
13.2.9.5.6.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 211
13.2.9.5.7 Spain: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 212
13.2.9.5.8 Spain: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 212
13.2.9.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 213
13.2.9.6.1 Overview.. 213
13.2.9.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 213
13.2.9.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 214
13.2.9.6.3.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 214
13.2.9.6.3.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 215
13.2.9.6.3.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 215
13.2.9.6.3.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 215
13.2.9.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 216
13.2.9.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 216
13.2.9.6.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 217
13.2.9.6.6.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 217
13.2.9.6.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 218
13.2.9.6.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 218
13.2.9.6.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 219
13.2.9.6.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 219
13.2.9.6.7 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 220
13.2.9.6.8 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 220
13.3 Asia Pacific: Gastric Cancer Diagnostic Procedure Market 221
13.3.1 Overview.. 221
13.3.2 Asia Pacific: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 222
13.3.3 Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 222
13.3.3.1 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 223
13.3.3.2 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 223
13.3.3.3 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 223
13.3.3.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 224
13.3.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 224
13.3.5 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 225
13.3.6 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 225
13.3.6.1 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 226
13.3.6.2 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 226
13.3.6.3 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 226
13.3.6.4 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 227
13.3.6.5 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 227
13.3.7 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 228
13.3.8 Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 228
13.3.9 Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Country. 229
13.3.9.1 China: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 229
13.3.9.1.1 Overview.. 229
13.3.9.1.2 China Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 229
13.3.9.1.3 China Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 230
13.3.9.1.3.1 China Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 231
13.3.9.1.3.2 China Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 231
13.3.9.1.3.3 China Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 231
13.3.9.1.3.4 China Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 232
13.3.9.1.4 China Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 232
13.3.9.1.5 China Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 233
13.3.9.1.6 China Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 233
13.3.9.1.6.1 China Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 234
13.3.9.1.6.2 China Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 234
13.3.9.1.6.3 China Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 235
13.3.9.1.6.4 China Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 235
13.3.9.1.6.5 China Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 236
13.3.9.1.7 China Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 236
13.3.9.1.8 China Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 237
13.3.9.2 Japan: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 238
13.3.9.2.1 Overview.. 238
13.3.9.2.2 Japan: Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million) 238
13.3.9.2.3 Japan: Gastric Cancer Diagnostic Procedure Market, by Healthcare providers, 2019–2028 (US$ Million) 239
13.3.9.2.3.1 Japan: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 239
13.3.9.2.3.2 Japan: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 240
13.3.9.2.3.3 Japan: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 240
13.3.9.2.3.4 Japan: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 240
13.3.9.2.4 Japan: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 241
13.3.9.2.5 Japan: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 241
13.3.9.2.6 Japan: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 242
13.3.9.2.6.1 Japan: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 242
13.3.9.2.6.2 Japan: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 243
13.3.9.2.6.3 Japan: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 243
13.3.9.2.6.4 Japan Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 244
13.3.9.2.6.5 Japan Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 244
13.3.9.2.7 Japan Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 245
13.3.9.2.8 Japan Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 245
13.3.9.3 India: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 246
13.3.9.3.1 Overview.. 246
13.3.9.3.2 India: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 246
13.3.9.3.3 India: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 247
13.3.9.3.3.1 India: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 248
13.3.9.3.3.2 India: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 248
13.3.9.3.3.3 India: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 248
13.3.9.3.3.4 India: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 249
13.3.9.3.4 India: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 249
13.3.9.3.5 India: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 250
13.3.9.3.6 India: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 250
13.3.9.3.6.1 India: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 251
13.3.9.3.6.2 India: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 251
13.3.9.3.6.3 India: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 251
13.3.9.3.6.4 India: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 252
13.3.9.3.6.5 India: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 252
13.3.9.3.7 India: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 253
13.3.9.3.8 India: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 253
13.3.9.4 South Korea: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 254
13.3.9.4.1 Overview.. 254
13.3.9.4.2 South Korea: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 254
13.3.9.4.3 South Korea: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 255
13.3.9.4.3.1 South Korea: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 255
13.3.9.4.3.2 South Korea: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 256
13.3.9.4.3.3 South Korea: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 256
13.3.9.4.3.4 South Korea: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 256
13.3.9.4.4 South Korea: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 257
13.3.9.4.5 South Korea: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 257
13.3.9.4.6 South Korea: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 258
13.3.9.4.6.1 South Korea: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 258
13.3.9.4.6.2 South Korea: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 259
13.3.9.4.6.3 South Korea: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 259
13.3.9.4.6.4 South Korea: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 260
13.3.9.4.6.5 South Korea: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 260
13.3.9.4.7 South Korea: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 261
13.3.9.4.8 South Korea: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 261
13.3.9.5 Australia: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 262
13.3.9.5.1 Overview.. 262
13.3.9.5.2 Australia: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 262
13.3.9.5.3 Australia: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 263
13.3.9.5.3.1 Australia: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 263
13.3.9.5.3.2 Australia: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 263
13.3.9.5.3.3 Australia: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 264
13.3.9.5.3.4 Australia: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 264
13.3.9.5.4 Australia: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 265
13.3.9.5.5 Australia: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 265
13.3.9.5.6 Australia: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 266
13.3.9.5.6.1 Australia: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 266
13.3.9.5.6.2 Australia: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 267
13.3.9.5.6.3 Australia: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 267
13.3.9.5.6.4 Australia: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 268
13.3.9.5.6.5 Australia: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 268
13.3.9.5.7 Australia: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 269
13.3.9.5.8 Australia: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 269
13.3.9.6 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 270
13.3.9.6.1 Overview.. 270
13.3.9.6.2 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 270
13.3.9.6.3 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 271
13.3.9.6.3.1 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 271
13.3.9.6.3.2 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 272
13.3.9.6.3.3 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 272
13.3.9.6.3.4 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 272
13.3.9.6.4 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 273
13.3.9.6.5 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 273
13.3.9.6.6 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 274
13.3.9.6.6.1 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 274
13.3.9.6.6.2 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 275
13.3.9.6.6.3 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 275
13.3.9.6.6.4 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 276
13.3.9.6.6.5 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 276
13.3.9.6.7 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 277
13.3.9.6.8 Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 277
13.4 South & Central America: Gastric Cancer Diagnostic Procedure Market 278
13.4.1 Overview.. 278
13.4.2 South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 279
13.4.3 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 279
13.4.3.1 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 280
13.4.3.2 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 280
13.4.3.3 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 280
13.4.3.4 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 281
13.4.4 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 281
13.4.5 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 282
13.4.6 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 282
13.4.6.1 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 283
13.4.6.2 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 283
13.4.6.3 South & Central America: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 284
13.4.6.4 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 284
13.4.6.5 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 285
13.4.7 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 285
13.4.8 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 286
13.4.9 South & Central America: Gastric Cancer Diagnostic Procedure Market, by Country. 286
13.4.9.1 Brazil: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 287
13.4.9.1.1 Overview.. 287
13.4.9.1.2 Brazil: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 287
13.4.9.1.3 Brazil: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 288
13.4.9.1.3.1 Brazil: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 288
13.4.9.1.3.2 Brazil: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 289
13.4.9.1.3.3 Brazil: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 289
13.4.9.1.3.4 Brazil: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 289
13.4.9.1.4 Brazil: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 290
13.4.9.1.5 Brazil: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 290
13.4.9.1.6 Brazil: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 291
13.4.9.1.6.1 Brazil: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 291
13.4.9.1.6.2 Brazil: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 292
13.4.9.1.6.3 Brazil: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 292
13.4.9.1.6.4 Brazil: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 293
13.4.9.1.6.5 Brazil: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 293
13.4.9.1.7 Brazil: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 294
13.4.9.1.8 Brazil: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 294
13.4.9.2 Argentina: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 295
13.4.9.2.1 Overview.. 295
13.4.9.2.2 Argentina: Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million) 295
13.4.9.2.3 Argentina: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 296
13.4.9.2.3.1 Argentina: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 296
13.4.9.2.3.2 Argentina: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 297
13.4.9.2.3.3 Argentina: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 297
13.4.9.2.3.4 Argentina: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 297
13.4.9.2.4 Argentina: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 298
13.4.9.2.5 Argentina: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 298
13.4.9.2.6 Argentina: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 299
13.4.9.2.6.1 Argentina: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 299
13.4.9.2.6.2 Argentina: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 300
13.4.9.2.6.3 Argentina: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 300
13.4.9.2.6.4 Argentina: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 301
13.4.9.2.6.5 Argentina: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 301
13.4.9.2.7 Argentina: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 302
13.4.9.2.8 Argentina: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 302
13.4.9.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 303
13.4.9.3.1 Overview.. 303
13.4.9.3.2 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 303
13.4.9.3.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 304
13.4.9.3.3.1 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 305
13.4.9.3.3.2 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 305
13.4.9.3.3.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 305
13.4.9.3.3.4 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 306
13.4.9.3.4 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 306
13.4.9.3.5 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 307
13.4.9.3.6 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 307
13.4.9.3.6.1 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 308
13.4.9.3.6.2 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 308
13.4.9.3.6.3 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million) 309
13.4.9.3.6.4 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 309
13.4.9.3.6.5 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 310
13.4.9.3.7 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 310
13.4.9.3.8 Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 311
13.5 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market 312
13.5.1 Overview.. 312
13.5.2 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 313
13.5.3 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 313
13.5.3.1 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 314
13.5.3.2 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 314
13.5.3.3 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 314
13.5.3.4 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 315
13.5.4 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 315
13.5.5 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 316
13.5.6 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 316
13.5.6.1 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 317
13.5.6.2 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 317
13.5.6.3 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 318
13.5.6.4 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 318
13.5.6.5 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 319
13.5.7 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 319
13.5.8 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 320
13.5.9 Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Country. 320
13.5.9.1 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 321
13.5.9.1.1 Overview.. 321
13.5.9.1.2 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 321
13.5.9.1.3 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 322
13.5.9.1.3.1 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 322
13.5.9.1.3.2 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 323
13.5.9.1.3.3 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 323
13.5.9.1.3.4 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 323
13.5.9.1.4 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 324
13.5.9.1.5 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 324
13.5.9.1.6 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 325
13.5.9.1.6.1 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 325
13.5.9.1.6.2 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 326
13.5.9.1.6.3 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 326
13.5.9.1.6.4 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 327
13.5.9.1.6.5 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 327
13.5.9.1.7 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 328
13.5.9.1.8 Saudi Arabia: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 328
13.5.9.2 South Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 329
13.5.9.2.1 Overview.. 329
13.5.9.2.2 South Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 329
13.5.9.2.3 South Africa: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 330
13.5.9.2.3.1 South Africa: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 330
13.5.9.2.3.2 South Africa: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 331
13.5.9.2.3.3 South Africa: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 331
13.5.9.2.3.4 South Africa: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 331
13.5.9.2.4 South Africa: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 332
13.5.9.2.5 South Africa: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 332
13.5.9.2.6 South Africa: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 333
13.5.9.2.6.1 South Africa: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 333
13.5.9.2.6.2 South Africa: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 334
13.5.9.2.6.3 South Africa: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 334
13.5.9.2.6.4 South Africa: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 335
13.5.9.2.6.5 South Africa: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 335
13.5.9.2.7 South Africa: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 336
13.5.9.2.8 South Africa: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 336
13.5.9.3 UAE: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 337
13.5.9.3.1 Overview.. 337
13.5.9.3.2 UAE: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 337
13.5.9.3.3 UAE: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 338
13.5.9.3.3.1 UAE: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 338
13.5.9.3.3.2 UAE: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 338
13.5.9.3.3.3 UAE: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 339
13.5.9.3.3.4 UAE: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 339
13.5.9.3.4 UAE: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 340
13.5.9.3.5 UAE: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 340
13.5.9.3.6 UAE: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 341
13.5.9.3.6.1 UAE: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 341
13.5.9.3.6.2 UAE: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 342
13.5.9.3.6.3 UAE: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 342
13.5.9.3.6.4 UAE: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 343
13.5.9.3.6.5 UAE: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 343
13.5.9.3.7 UAE: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 344
13.5.9.3.8 UAE: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 344
13.5.9.4 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 345
13.5.9.4.1 Overview.. 345
13.5.9.4.2 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 345
13.5.9.4.3 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million) 346
13.5.9.4.3.1 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million) 346
13.5.9.4.3.2 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million) 347
13.5.9.4.3.3 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million) 347
13.5.9.4.3.4 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million) 347
13.5.9.4.4 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million) 348
13.5.9.4.5 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million) 348
13.5.9.4.6 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million) 349
13.5.9.4.6.1 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million) 349
13.5.9.4.6.2 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million) 350
13.5.9.4.6.3 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests, 2019–2028 (US$ Million) 350
13.5.9.4.6.4 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million) 351
13.5.9.4.6.5 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million) 351
13.5.9.4.7 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million) 352
13.5.9.4.8 Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million) 352
14. Impact Of COVID-19 Pandemic on Gastric Cancer Diagnostic Procedure Market 353
14.1 North America: Impact Assessment of COVID-19 Pandemic. 353
14.2 Europe: Impact Assessment of COVID-19 Pandemic. 354
14.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic. 356
14.4 South & Central America: Impact Assessment of COVID-19 Pandemic. 358
14.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic. 359
15. Gastric Cancer Diagnostic Procedure Market – Industry Landscape 361
15.1 Overview.. 361
15.2 Growth Strategies Done by the Companies in the Market, (%) 361
15.3 Organic Developments. 362
15.3.1 Overview.. 362
15.4 Inorganic Developments. 363
15.4.1 Overview.. 363
16. Company Profiles 364
16.1 Atlas-Link Biotech Co Ltd. 364
16.1.1 Key Facts. 364
16.1.2 Business Description. 364
16.1.3 Products and Services. 364
16.1.4 Financial Overview.. 364
16.1.5 SWOT Analysis. 365
16.1.6 Key Developments. 365
16.2 Bio-Rad Laboratories Inc. 366
16.2.1 Key Facts. 366
16.2.2 Business Description. 366
16.2.3 Products and Services. 366
16.2.4 Financial Overview.. 367
16.2.5 SWOT Analysis. 368
16.2.6 Key Developments. 368
16.3 MiRXES Pte Ltd. 369
16.3.1 Key Facts. 369
16.3.2 Business Description. 369
16.3.3 Products and Services. 369
16.3.4 Financial Overview.. 369
16.3.5 SWOT Analysis. 370
16.3.6 Key Developments. 370
16.4 Agilent Technologies Inc. 371
16.4.1 Key Facts. 371
16.4.2 Business Description. 371
16.4.3 Products and Services. 371
16.4.4 Financial Overview.. 372
16.4.5 SWOT Analysis. 373
16.4.6 Key Developments. 374
16.5 F. Hoffmann-La Roche Ltd. 375
16.5.1 Key Facts. 375
16.5.2 Business Description. 375
16.5.3 Products and Services. 376
16.5.4 Financial Overview.. 376
16.5.5 SWOT Analysis. 378
16.5.6 Key Developments. 378
16.6 bioMerieux SA. 379
16.6.1 Key Facts. 379
16.6.2 Business Description. 379
16.6.3 Products and Services. 379
16.6.4 Financial Overview.. 380
16.6.5 SWOT Analysis. 381
16.6.6 Key Developments. 381
16.7 Thermo Fisher Scientific Inc. 382
16.7.1 Key Facts. 382
16.7.2 Business Description. 382
16.7.3 Products and Services. 383
16.7.4 Financial Overview.. 384
16.7.5 SWOT Analysis. 385
16.7.6 Key Developments. 386
16.8 Illumina Inc. 387
16.8.1 Key Facts. 387
16.8.2 Business Description. 387
16.8.3 Products and Services. 387
16.8.4 Financial Overview.. 388
16.8.5 SWOT Analysis. 389
16.8.6 Key Developments. 390
16.9 Vela Diagnostics Holding Pte Ltd. 391
16.9.1 Key Facts. 391
16.9.2 Business Description. 391
16.9.3 Products and Services. 391
16.9.4 Financial Overview.. 392
16.9.5 SWOT Analysis. 392
16.9.6 Key Developments. 392
16.10 Myraid Genetics Inc. 393
16.10.1 Key Facts. 393
16.10.2 Business Description. 393
16.10.3 Products and Services. 393
16.10.4 Financial Overview.. 394
16.10.5 SWOT Analysis. 395
16.10.6 Key Developments. 395
17. Appendix 396
17.1 About The Insight Partners. 396
17.2 Glossary of Terms. 396
LIST OF TABLES
Table 1. North America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 130
Table 2. North America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 131
Table 3. North America: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 131
Table 4. North America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 131
Table 5. North America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 132
Table 6. North America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 132
Table 7. North America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 133
Table 8. North America: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 133
Table 9. North America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 134
Table 10. North America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 134
Table 11. North America: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 134
Table 12. North America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 135
Table 13. North America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 135
Table 14. North America: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 136
Table 15. North America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 136
Table 16. United States: Gastric cancer diagnostic procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 138
Table 17. United States: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 139
Table 18. United States: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 139
Table 19. United States: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 140
Table 20. United States: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 140
Table 21. United States: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 140
Table 22. United States: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 141
Table 23. United States: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 141
Table 24. United States: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 142
Table 25. United States: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 142
Table 26. United States: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 143
Table 27. United States: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 143
Table 28. United States: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 144
Table 29. United States: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 144
Table 30. United States: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 145
Table 31. Canada Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 147
Table 32. Canada Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 148
Table 33. Canada Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 148
Table 34. Canada Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 148
Table 35. Canada Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 149
Table 36. Canada Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 149
Table 37. Canada Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 150
Table 38. Canada Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 150
Table 39. Canada Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 151
Table 40. Canada Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 151
Table 41. Canada Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 152
Table 42. Canada Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 152
Table 43. Canada Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 153
Table 44. Canada Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 153
Table 45. Canada Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 154
Table 46. Mexico Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 156
Table 47. Mexico Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 156
Table 48. Mexico Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 157
Table 49. Mexico Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 157
Table 50. Mexico Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 157
Table 51. Mexico Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 158
Table 52. Mexico Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 158
Table 53. Mexico Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 159
Table 54. Mexico Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 159
Table 55. Mexico Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 160
Table 56. Mexico Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 160
Table 57. Mexico Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 161
Table 58. Mexico Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 161
Table 59. Mexico Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 162
Table 60. Mexico Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 162
Table 61. Europe Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 164
Table 62. Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 165
Table 63. Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 165
Table 64. Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 165
Table 65. Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 166
Table 66. Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 166
Table 67. Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 166
Table 68. Europe Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 167
Table 69. Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 167
Table 70. Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 168
Table 71. Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 168
Table 72. Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 169
Table 73. Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 169
Table 74. Europe Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 170
Table 75. Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 170
Table 76. Germany Gastric cancer diagnostic procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 172
Table 77. Germany Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 173
Table 78. Germany Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 173
Table 79. Germany Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 173
Table 80. Germany Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 174
Table 81. Germany Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 174
Table 82. Germany Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 175
Table 83. Germany Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 175
Table 84. Germany Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 176
Table 85. Germany Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 176
Table 86. Germany Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 177
Table 87. Germany Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 177
Table 88. Germany Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 178
Table 89. Germany Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 178
Table 90. Germany Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 179
Table 91. France Gastric Cancer Diagnostic Procedure Market, by Healthcare providers – Revenue and Forecast to 2028 (US$ Million) 181
Table 92. France Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 182
Table 93. France Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 182
Table 94. France Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 182
Table 95. France Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 183
Table 96. France Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 183
Table 97. France Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 184
Table 98. France Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 184
Table 99. France Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 185
Table 100. France Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 185
Table 101. France Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 186
Table 102. France Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 186
Table 103. France Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 187
Table 104. France Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 187
Table 105. France Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 188
Table 106. UK Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 190
Table 107. UK Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 191
Table 108. UK Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 191
Table 109. UK Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 191
Table 110. UK Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 192
Table 111. UK Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 192
Table 112. UK Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 192
Table 113. UK Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 193
Table 114. UK Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 193
Table 115. UK Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 194
Table 116. UK Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 194
Table 117. UK Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 195
Table 118. UK Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 195
Table 119. UK Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 196
Table 120. UK Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 196
Table 121. Italy Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 198
Table 122. Italy Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 198
Table 123. Italy Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 199
Table 124. Italy Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 199
Table 125. Italy Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 199
Table 126. Italy Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 200
Table 127. Italy Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 200
Table 128. Italy Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 201
Table 129. Italy Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 201
Table 130. Italy Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 202
Table 131. Italy Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 202
Table 132. Italy Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 203
Table 133. Italy Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 203
Table 134. Italy Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 204
Table 135. Italy Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 204
Table 136. Spain Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 206
Table 137. Spain Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 206
Table 138. Spain Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 206
Table 139. Spain Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 207
Table 140. Spain Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 207
Table 141. Spain Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 208
Table 142. Spain Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 208
Table 143. Spain Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 209
Table 144. Spain Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 209
Table 145. Spain Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 210
Table 146. Spain Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 210
Table 147. Spain Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 211
Table 148. Spain Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 211
Table 149. Spain Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 212
Table 150. Spain Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 212
Table 151. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 214
Table 152. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 214
Table 153. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 215
Table 154. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 215
Table 155. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 215
Table 156. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 216
Table 157. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 216
Table 158. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 217
Table 159. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 217
Table 160. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 218
Table 161. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 218
Table 162. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 219
Table 163. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 219
Table 164. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 220
Table 165. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 220
Table 166. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 222
Table 167. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 223
Table 168. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 223
Table 169. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 223
Table 170. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 224
Table 171. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 224
Table 172. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 225
Table 173. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 225
Table 174. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 226
Table 175. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 226
Table 176. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 226
Table 177. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 227
Table 178. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 227
Table 179. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 228
Table 180. Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 228
Table 181. China Gastric cancer diagnostic procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 230
Table 182. China Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 231
Table 183. China Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 231
Table 184. China Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 231
Table 185. China Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 232
Table 186. China Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 232
Table 187. China Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 233
Table 188. China Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 233
Table 189. China Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 234
Table 190. China Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 234
Table 191. China Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 235
Table 192. China Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 235
Table 193. China Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 236
Table 194. China Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 236
Table 195. China Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 237
Table 196. Japan Gastric Cancer Diagnostic Procedure Market, by Healthcare providers – Revenue and Forecast to 2028 (US$ Million) 239
Table 197. Japan Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 239
Table 198. Japan Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 240
Table 199. Japan Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 240
Table 200. Japan Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 240
Table 201. Japan Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 241
Table 202. Japan Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 241
Table 203. Japan Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 242
Table 204. Japan Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 242
Table 205. Japan Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 243
Table 206. Japan Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 243
Table 207. Japan Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 244
Table 208. Japan Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 244
Table 209. Japan Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 245
Table 210. Japan Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 245
Table 211. India Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 247
Table 212. India Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 248
Table 213. India Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 248
Table 214. India Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 248
Table 215. India Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 249
Table 216. India Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 249
Table 217. India Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 250
Table 218. India Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 250
Table 219. India Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 251
Table 220. India Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 251
Table 221. India Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 251
Table 222. India Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 252
Table 223. India Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 252
Table 224. India Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 253
Table 225. India Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 253
Table 226. South Korea Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 255
Table 227. South Korea Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 255
Table 228. South Korea Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 256
Table 229. South Korea Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 256
Table 230. South Korea Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 256
Table 231. South Korea Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 257
Table 232. South Korea Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 257
Table 233. South Korea Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 258
Table 234. South Korea Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 258
Table 235. South Korea Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 259
Table 236. South Korea Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 259
Table 237. South Korea Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 260
Table 238. South Korea Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 260
Table 239. South Korea Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 261
Table 240. South Korea Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 261
Table 241. Australia Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 263
Table 242. Australia Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 263
Table 243. Australia Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 263
Table 244. Australia Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 264
Table 245. Australia Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 264
Table 246. Australia Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 265
Table 247. Australia Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 265
Table 248. Australia Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 266
Table 249. Australia Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 266
Table 250. Australia Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 267
Table 251. Australia Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 267
Table 252. Australia Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 268
Table 253. Australia Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 268
Table 254. Australia Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 269
Table 255. Australia Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 269
Table 256. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 271
Table 257. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 271
Table 258. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 272
Table 259. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 272
Table 260. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 272
Table 261. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 273
Table 262. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 273
Table 263. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 274
Table 264. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 274
Table 265. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 275
Table 266. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 275
Table 267. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 276
Table 268. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 276
Table 269. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 277
Table 270. Rest of Asia Pacific Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 277
Table 271. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 279
Table 272. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 280
Table 273. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 280
Table 274. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 280
Table 275. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 281
Table 276. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 281
Table 277. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 282
Table 278. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 282
Table 279. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 283
Table 280. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 283
Table 281. South & Central America: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 284
Table 282. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 284
Table 283. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 285
Table 284. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 285
Table 285. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 286
Table 286. Brazil: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 288
Table 287. Brazil: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 288
Table 288. Brazil: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 289
Table 289. Brazil: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 289
Table 290. Brazil: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 289
Table 291. Brazil: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 290
Table 292. Brazil: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 290
Table 293. Brazil: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 291
Table 294. Brazil: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 291
Table 295. Brazil: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 292
Table 296. Brazil: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 292
Table 297. Brazil: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 293
Table 298. Brazil: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 293
Table 299. Brazil: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 294
Table 300. Brazil: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 294
Table 301. Argentina: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 296
Table 302. Argentina: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 296
Table 303. Argentina: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 297
Table 304. Argentina: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 297
Table 305. Argentina: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 297
Table 306. Argentina: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 298
Table 307. Argentina: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 298
Table 308. Argentina: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 299
Table 309. Argentina: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 299
Table 310. Argentina: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 300
Table 311. Argentina: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 300
Table 312. Argentina: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 301
Table 313. Argentina: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 301
Table 314. Argentina: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 302
Table 315. Argentina: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 302
Table 316. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 304
Table 317. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 305
Table 318. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 305
Table 319. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 305
Table 320. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 306
Table 321. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 306
Table 322. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 307
Table 323. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 307
Table 324. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 308
Table 325. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 308
Table 326. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 309
Table 327. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 309
Table 328. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 310
Table 329. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 310
Table 330. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 311
Table 331. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 313
Table 332. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 314
Table 333. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 314
Table 334. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 314
Table 335. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 315
Table 336. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 315
Table 337. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 316
Table 338. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 316
Table 339. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 317
Table 340. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 317
Table 341. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 318
Table 342. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 318
Table 343. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 319
Table 344. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 319
Table 345. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 320
Table 346. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 322
Table 347. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 322
Table 348. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 323
Table 349. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 323
Table 350. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 323
Table 351. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 324
Table 352. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 324
Table 353. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 325
Table 354. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 325
Table 355. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 326
Table 356. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 326
Table 357. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 327
Table 358. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 327
Table 359. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 328
Table 360. Saudi Arabia Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 328
Table 361. South Africa Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 330
Table 362. South Africa Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 330
Table 363. South Africa Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 331
Table 364. South Africa Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 331
Table 365. South Africa Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 331
Table 366. South Africa Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 332
Table 367. South Africa Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 332
Table 368. South Africa Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 333
Table 369. South Africa Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 333
Table 370. South Africa Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 334
Table 371. South Africa Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 334
Table 372. South Africa Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 335
Table 373. South Africa Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 335
Table 374. South Africa Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 336
Table 375. South Africa Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 336
Table 376. UAE Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 338
Table 377. UAE Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 338
Table 378. UAE Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 338
Table 379. UAE Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 339
Table 380. UAE Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 339
Table 381. UAE Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 340
Table 382. UAE Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 340
Table 383. UAE Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 341
Table 384. UAE Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 341
Table 385. UAE Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 342
Table 386. UAE Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 342
Table 387. UAE Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 343
Table 388. UAE Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 343
Table 389. UAE Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 344
Table 390. UAE Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 344
Table 391. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million) 346
Table 392. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million) 346
Table 393. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million) 347
Table 394. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million) 347
Table 395. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million) 347
Table 396. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million) 348
Table 397. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million) 348
Table 398. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million) 349
Table 399. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million) 349
Table 400. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million) 350
Table 401. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by In-Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million) 350
Table 402. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million) 351
Table 403. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million) 351
Table 404. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million) 352
Table 405. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million) 352
Table 406. Organic Developments Done by Companies. 362
Table 407. Inorganic Developments Done by Companies. 363
Table 408. Glossary of Terms. 396
LIST OF FIGURES
Figure 1. Gastric Cancer Diagnostic Procedure Market Segmentation. 67
Figure 2. Gastric Cancer Diagnostic Procedure Market, by Region. 68
Figure 3. Global Gastric Cancer Diagnostic Procedure Market Overview.. 72
Figure 4. Asymptomatic Segment Held a Larger Share From Symptom Type Segment in Gastric Cancer Diagnostic Procedure Market 73
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period. 74
Figure 6. Gastric Cancer Diagnostic Procedure Market, by Geography (US$ Million) 75
Figure 7. Global Gastric Cancer Diagnostic Procedure Market – Leading Country Markets (US$ Million) 76
Figure 8. Global Gastric Cancer Diagnostic Procedure Market – Industry Landscape. 77
Figure 9. North America: PEST Analysis. 81
Figure 10. Europe: PEST Analysis. 82
Figure 11. Asia Pacific: PEST Analysis. 82
Figure 12. South & Central America: PEST Analysis. 83
Figure 13. Middle East & Africa: PEST Analysis. 83
Figure 14. Experts’ Opinion. 84
Figure 15. Gastric Cancer Diagnostic Procedure Market: Impact Analysis of Drivers and Restraints. 88
Figure 16. Global Gastric Cancer Diagnostic Procedure Market – Revenue Forecast and Analysis – 2020–2028. 89
Figure 17. Global Gastric Cancer Diagnostic Procedure Market, by Geography – Forecast and Analysis (2020–2028) 90
Figure 18. Market Positioning of Key Players in Gastric Cancer Diagnostic Procedure Market 91
Figure 19. Global Gastric Cancer Diagnostic Procedure Market – Market Potential Analysis, by Region. 91
Figure 20. Global Gastric Cancer Diagnostic Procedure Market – Comparative Company Analysis. 92
Figure 21. Global Gastric Cancer Diagnostic Procedure Market – Growth Strategy Analysis. 93
Figure 22. Global Gastric Cancer Diagnostic Procedure, by Healthcare Providers, 2021 & 2028 (%) 96
Figure 23. Diagnostic Laboratories: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 97
Figure 24. Hospitals: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 98
Figure 25. Cancer Research Institutes: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 99
Figure 26. Oncology Specialty Clinics: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 100
Figure 27. Others: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 101
Figure 28. Global Gastric Cancer Diagnostic Procedure, by Symptom Type, 2021 & 2028 (%) 102
Figure 29. Symptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 103
Figure 30. Asymptomatic: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 104
Figure 31. Global Gastric Cancer Diagnostic Procedure, by Body Fluid, 2021 & 2028 (%) 105
Figure 32. Blood: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 106
Figure 33. Urine: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 107
Figure 34. Saliva: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 108
Figure 35. Stomach Wash/Gastric Juice: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 109
Figure 36. Tissue: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 110
Figure 37. Other: Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million) 111
Figure 38. Global Gastric Cancer Diagnostic Procedure, by Procedures, 2021 & 2028 (%) 112
Figure 39. Endoscopic Procedure: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 113
Figure 40. Biopsy and Tissue Tests: Global Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million) 114
Figure 41. Lab Tests: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 115
Figure 42. In-Vitro Diagnostic Tests: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 116
Figure 43. Imaging Tests: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 117
Figure 44. Molecular Diagnostics: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 118
Figure 45. Multiplexing Molecular Diagnostics and Immunoassay: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 120
Figure 46. Others: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 121
Figure 47. Global Gastric Cancer Diagnostic Procedure, by Offerings, 2021 & 2028 (%) 122
Figure 48. Instruments: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 123
Figure 49. Reagents and Consumables: Global Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 124
Figure 50. Services: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 125
Figure 51. Global Gastric Cancer Diagnostic Procedure, by Disease Indication, 2021 & 2028 (%) 126
Figure 52. Early Gastric Cancer: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 127
Figure 53. Gastric Cancer Advanced Types: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million) 128
Figure 54. North America: Gastric Cancer Diagnostic Procedure Market, by Key Country – Revenue (2021) (US$ Million) 129
Figure 55. North America Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 130
Figure 56. North America: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%) 137
Figure 57. United States: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 138
Figure 58. Canada: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 147
Figure 59. Mexico: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 155
Figure 60. Europe: Gastric Cancer Diagnostic Procedure Market, by Key Country – Revenue (2021) (US$ Million) 163
Figure 61. Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 164
Figure 62. Europe: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%) 171
Figure 63. Germany Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 172
Figure 64. France: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 181
Figure 65. UK: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 190
Figure 66. Italy: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 197
Figure 67. Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 205
Figure 68. Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 213
Figure 69. Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Key Country – Revenue (2021) (US$ Million) 221
Figure 70. Asia Pacific Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 222
Figure 71. Asia Pacific: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%) 229
Figure 72. China Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 230
Figure 73. Japan: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 238
Figure 74. India: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 247
Figure 75. South Korea: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 254
Figure 76. Australia: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 262
Figure 77. Rest of Asia Pacific: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 270
Figure 78. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Key Country – Revenue (2021) (US$ Million) 278
Figure 79. South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 279
Figure 80. South & Central America: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%) 286
Figure 81. Brazil: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 287
Figure 82. Argentina: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 295
Figure 83. Rest of South & Central America: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 304
Figure 84. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Key Country – Revenue (2021) (US$ Million) 312
Figure 85. Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 313
Figure 86. Middle East & Africa: Gastric Cancer Diagnostic Procedure Market, by Country, 2021 & 2028 (%) 320
Figure 87. Saudi Arabia: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 321
Figure 88. South Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 329
Figure 89. UAE: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 337
Figure 90. Rest of Middle East & Africa: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million) 345
Figure 91. Impact of COVID-19 Pandemic on North American Country Markets. 353
Figure 92. Impact of COVID-19 Pandemic in European Country Markets. 355
Figure 93. Impact of COVID-19 Pandemic on Asia Pacific Country Markets. 357
Figure 94. Impact of COVID-19 Pandemic on South & Central American Country Markets. 359
Figure 95. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets. 360
Figure 96. Growth Strategies Done by the Companies in the Market, (%) 361
The List of Companies - Gastric Cancer Diagnostic Procedure Market
- Atlas-Link Biotech Co Ltd
- Bio-Rad Laboratories Inc
- MiRXES Pte Ltd
- Agilent Technologies Inc
- F. Hoffmann-La Roche Ltd
- bioMerieux SA
- Thermo Fisher Scientific Inc
- Illumina Inc
- Vela Diagnostics Holding Pte Ltd
- Myraid Genetics Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Gastric Cancer Diagnostic Procedure Market
Feb 2023
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Feb 2023
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Feb 2023
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Feb 2023
Electronic Patient-Reported Outcomes (ePROS) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others], and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
Wellbeing Platform Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service (Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition & Weight Management, Stress Management, Comprehensive Wellbeing, and Others), Category (Fitness & Nutrition Consultant, Psychological Therapists, and Organization/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organization, and Homecare), and Geography
Feb 2023
Smart Hospital Beds Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Patient Weight (Less than 70 lb, 70 to 150 lb, 150 to 400 lb, 400 to 500 lb, Greater than 500 lb); Offering (Products and Accessories, Software and Solutions, and Services); Application (Fall Prevention, Pressure Injury Prevention, Patient Deterioration and Monitoring, and Others); End User (Hospitals, Clinics and Nursing Homes, Ambulatory Surgical Centers, Medical Laboratories, Long Term Care Centers, and Others), and Geography